Attached files
Exhibit 32.1
CERTIFICATION PURSUANT TO
SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
Pursuant to Section 1350, Chapter 63 of Title 18, United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned, as principal executive officer and principal financial officer of EPIRUS Biopharmaceuticals, Inc. (the “Company”), do hereby certify that to their knowledge:
| 2) | the Company’s Form 10-Q for the fiscal quarter ended June 30, 2014 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| 3) | the information contained in the Company’s Form 10-Q for the fiscal quarter ended June 30, 2014 fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| /s/ Amit Munshi |
| Amit Munshi |
| President and Chief Executive Officer |
| (principal executive officer) |
| /s/ Thomas Shea |
| Thomas Shea |
| Chief Financial Officer and Treasurer |
| (principal financial officer) |
Dated: August 11, 2014